Table 5.

Therapeutic options for patients prior to and after liver transplantation

Genotype	Population	Drugs	Duration of therapy
1, 2, 3, 4, 5, 6	Approved for liver transplantation	SOF + RBV	Until transplantation, not longer than 24 weeks
1, 4		PTV/OBV/r + DSV + RBV (G1) PTV/OBV/r + RBV (G4) SOF/LDV + RBV	12 weeks in G1b infection (if Child-Pugh A; 24 weeks in G1a or G4 infection) 24 weeks
1, 3, 4, 5, 6	Post liver transplantation	SOF + DCV +/– RBV	12-24 weeks
2		SOF + RBV	12-24 weeks
1, 4		PTV/OBV/r + DSV + RBV (G1) PTV/OBV/r + RBV (G4) SOF/LDV + RBV SOF + SMV +/– RBV	24 weeks 24 weeks 24 weeks 12-24 weeks